pI: 7.3114 |
Length (AA): 820 |
MW (Da): 92193 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128360)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G28740 | tetratricopeptide repeat domain-containing protein |
Babesia bovis | BBOV_IV000660 | XBA-binding protein 2, putative |
Brugia malayi | Bm1_33965 | XPA-binding protein 2 |
Candida albicans | CaO19.10411 | RNA splicing |
Candida albicans | CaO19.2893 | RNA splicing |
Caenorhabditis elegans | CELE_C50F2.3 | Protein C50F2.3 |
Cryptosporidium hominis | Chro.70121 | ENSANGP00000023353 |
Cryptosporidium parvum | cgd7_970 | Syf1p. protein with 8 HAT domains |
Dictyostelium discoideum | DDB_G0277977 | TPR-like helical domain-containing protein |
Drosophila melanogaster | Dmel_CG6197 | CG6197 gene product from transcript CG6197-RA |
Echinococcus granulosus | EgrG_000237200 | pre mRNA splicing factor SYF1 |
Entamoeba histolytica | EHI_073290 | hypothetical protein |
Entamoeba histolytica | EHI_073300 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000237200 | pre mRNA splicing factor SYF1 |
Homo sapiens | ENSG00000076924 | XPA binding protein 2 |
Leishmania braziliensis | LbrM.23.1790 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_231950.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.23.1950 | hypothetical protein, conserved |
Leishmania major | LmjF.23.1550 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.23.1550 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_08885 | hypothetical protein |
Loa Loa (eye worm) | LOAG_16272 | hypothetical protein |
Loa Loa (eye worm) | LOAG_08304 | XPA-binding protein 2 |
Mus musculus | ENSMUSG00000019470 | XPA binding protein 2 |
Neospora caninum | NCLIV_001120 | XPA-binding protein, putative |
Oryza sativa | 4344088 | Os07g0644300 |
Plasmodium berghei | PBANKA_1450500 | pre-mRNA-splicing factor SYF1, putative |
Plasmodium falciparum | PF3D7_1235900 | pre-mRNA-splicing factor SYF1, putative |
Plasmodium knowlesi | PKNH_1455600 | pre-mRNA-splicing factor SYF1, putative |
Plasmodium vivax | PVX_100745 | pre-mRNA-splicing factor SYF1, putative |
Plasmodium yoelii | PY00967 | Homo sapiens KIAA1177 protein |
Saccharomyces cerevisiae | YDR416W | Syf1p |
Schistosoma japonicum | Sjp_0071210 | Pre-mRNA-splicing factor SYF1, putative |
Schistosoma mansoni | Smp_166240 | hcnp homolog |
Schmidtea mediterranea | mk4.003962.01 | Pre-mRNA-splicing factor SYF1 |
Schmidtea mediterranea | mk4.003190.01 | Pre-mRNA-splicing factor SYF1 |
Schmidtea mediterranea | mk4.011985.00 | Pre-mRNA-splicing factor SYF1 |
Trypanosoma brucei gambiense | Tbg972.5.1840 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.5.1340 | pre-mRNA splicing factor, putative |
Trypanosoma brucei | Tb11.v5.0884 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_0_29970 | HAT (Half-A-TPR) repeats, putative |
Trypanosoma congolense | TcIL3000_5_1380 | HAT (Half-A-TPR) repeats, putative |
Trypanosoma cruzi | TcCLB.509601.40 | pre-mRNA splicing factor, putative |
Trypanosoma cruzi | TcCLB.509767.40 | pre-mRNA splicing factor, putative |
Toxoplasma gondii | TGME49_305240 | XPA binding protein 2 family protein |
Theileria parva | TP01_0087 | adapter protein, putative |
Trichomonas vaginalis | TVAG_258450 | pre-mRNA splicing factor, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.1340 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.1340 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.1340 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.1340 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C50F2.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C50F2.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C50F2.3 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C50F2.3 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C50F2.3 | Caenorhabditis elegans | sterile | wormbase |
YDR416W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1450500 | Plasmodium berghei | Essential | plasmo |
TGME49_305240 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.